Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07208279 · ClinicalTrials.gov registry record · NA
Cognitive Vitality Pilot Study
A NA study of Aging and Healthy Aging, sponsored by Arizona State University.
- Recruiting
- Registry status
- NA
- Development phase
- 16
- Enrollment target
- 1
- Study location
NCT07208279: Recruiting NA study of Aging and Healthy Aging, sponsored by Arizona State University.
NCT07208279 is a NA study of Aging and Healthy Aging that is actively recruiting participants, run by Arizona State University. The registered enrollment target is 16 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07208279, a NA study of Aging and Healthy Aging, is actively recruiting participants, sponsored by Arizona State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
- 1
- Study location
Study Summary
This study's purpose is to evaluate the effects of a dietary supplement on cognitive function and psychological well-being in community-dwelling older adults aged 55+. The study involves taking a commercially available dietary supplement daily for 45 days. A 45-minute assessment will be conducted at the beginning and again at the end of the study.
Primary Outcome
Digit Span Forward measures short-term memory (5 min.) Score: Min = 2, Max = 8 \*Higher score means better outcome
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Axolt Brain Supplement
- DIETARY_SUPPLEMENT Bolero - Flavored Drink Placebo
Study Locations (1)
Florida
- Community - West Palm Beach
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2025-09-01 |
| Est. Completion | 2026-08-11 |
| Phase | NA |
What NCT07208279 shows while recruiting
NCT07208279 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower).
The record links to 5 conditions, with Aging appearing as the primary indexed condition, and to 2 interventions - of which Axolt Brain Supplement is the first listed.
NCT07208279 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT07208279 about?
NCT07208279 is a clinical study titled "Cognitive Vitality Pilot Study". This study's purpose is to evaluate the effects of a dietary supplement on cognitive function and psychological well-being in community-dwelling older adults aged 55+. The study involves taking a commercially available dietary supplement daily for 45 days. A 45-minute assessment will be conducted at...
What is the current status of trial NCT07208279?
This trial is currently recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2025-09-01. Estimated completion is 2026-08-11.
What conditions does trial NCT07208279 study?
This clinical trial studies the following conditions: Aging, Healthy Aging, Cognition, Memory, Brain.
What interventions are being tested in trial NCT07208279?
The interventions under investigation include: Axolt Brain Supplement (DIETARY_SUPPLEMENT), Bolero - Flavored Drink Placebo (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT07208279?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07208279 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Aging
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07208279's enrollment target sits among peer trials
16 246th of 262 higher than 13 of 262 other Aging trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Aging trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
Using Nicotine to Reverse Age-related Auditory Processing Deficits
RECRUITING · NA
-
Heterogeneity of Vascular Adaptations to Exercise With Aging in Women and Men
RECRUITING · NA
-
Modulating Neurocognitive Processes of Learning to Trust and Distrust in Aging
RECRUITING · NA
-
Studying the Effects of Digital Interventions on Cognition, Wellbeing, Stress, and Sleep in Older Adults
RECRUITING · NA
-
The GLUCID Study: Effect of Alcohol Reduction and Probiotic Interventions on Cognition and Brain Glucose Metabolism in Normal Aging Adults Who Are High-Risk Alcohol Drinkers
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI